Spots Global Cancer Trial Database for CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
Official Title: Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
Study ID: NCT04157569
Conditions
Interventions
Study Description
Brief Summary: This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Detailed Description: This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .
Keywords
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Navy General Hospital, Beijing, , China
Contact Details
Name: Liren Qian, MD
Affiliation: Navy General Hospital, Beijing
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
